Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

FIFO and FEFO in Pharmaceutical Warehouses: Why Both Matter

Posted on November 25, 2025November 25, 2025 By digi


FIFO and FEFO in Pharmaceutical Warehouses: Why Both Matter

Understanding FIFO and FEFO in Pharmaceutical Warehouses: A Step-by-Step Guide

Effective stock rotation is a critical component of pharmaceutical Good Manufacturing Practice (GMP) compliance. Implementing FIFO and FEFO in pharmaceutical warehouses ensures product quality, reduces waste, and supports regulatory expectations across the US, UK, and EU markets. These inventory management principles play pivotal roles in pharmaceutical supply chain and quality assurance systems by controlling expiry dates, batch integrity, and traceability. This step-by-step technical tutorial explains each principle, highlights their differences, and guides professionals through systematic implementation tailored to regulated pharmaceutical environments.

Step 1: Define FIFO and FEFO Principles in the Context of Pharma Warehouses

FIFO stands for First In, First Out. It is an inventory rotation method where the oldest stock—defined by receipt date into the warehouse—is issued or dispatched before newer stock. FIFO is designed to minimize stock aging and inventory obsolescence by ensuring that items physically received first leave the warehouse first.

FEFO, or First Expired, First Out, refines stock rotation by prioritizing the expiry date rather than the receipt date. Medicines, active pharmaceutical ingredients (APIs), and raw materials managed under FEFO are issued in an order based on soonest expiration to prevent product expiry or degradation within the warehouse. This method is especially important for products with varying shelf lives or those received out of chronological order.

Both principles support stock rotation but focus on different parameters:

  • FIFO focuses on the chronological arrival of goods in the warehouse.
  • FEFO prioritizes the minimization of expired stock by considering expiry dates.

Regulatory frameworks such as FDA 21 CFR Part 211 require adequate control of material stock rotation to assure drug product quality throughout the supply chain. Similarly, EU GMP Volume 4 Annex 15 mandates control over material shelf-life and appropriate stock rotation to prevent distribution of expired materials.

Also Read:  Warehouse SOP Template for FIFO and FEFO-Based Material Handling

Step 2: Identify Products Suitable for FIFO Versus FEFO Application

Understanding when to apply FIFO or FEFO is essential for pharmaceutical warehouses to maintain compliance and operational effectiveness. While some products require strict expiry-based rotation, others are effectively managed by first-in chronological order.

When to Use FIFO:

  • Non-expiry sensitive materials: Certain packaging components, equipment, and non-perishable excipients that do not have a strict expiry but still require orderly stock management.
  • Products with consistent or very long shelf lives: Where expiry risk is negligible through typical storage durations.
  • Raw materials with batch quality certification: If the controlled shelf life is monitored separately and expiry risk is low or uniform.

When to Use FEFO:

  • Finished drug products with variable expiration dates: Many pharmaceuticals possess differing expiry dates and potency degradation risks.
  • Active pharmaceutical ingredients (APIs): Particularly those sensitive to degradation and having critical expiry concerns.
  • Temperature-sensitive or multi-batch incoming goods: Where newer batches may arrive with shorter expiry periods than older stock.

Warehouses must categorize pharmaceutical items based on these criteria before assigning the rotation method. This process often requires cross-functional coordination between QA, supply chain, and manufacturing to ensure data accuracy for batch manufacturing records and Certificates of Analysis. Comprehensive documentation and labeling with expiry and receipt date information are crucial.

Step 3: Organize Warehouse Layout and Storage Systems to Support FIFO and FEFO

Proper physical and procedural setup of storage environments is critical for implementing FIFO and FEFO effectively.

Design Principles for FIFO Warehousing:

  • Linear or flow-through storage: Shelving or pallet racking aligned so that inbound stock is loaded at one end and outbound stock is picked from the other.
  • Clear identification labeling: Date-stamping or barcoding of received materials for visibility.
  • Standard operating procedures (SOPs): Established protocols to ensure workers pick oldest-stock first during order fulfillment.

Design Principles for FEFO Warehousing:

  • Expiry date segregation: Stock arranged by expiration date, often requiring flexible shelving to accommodate varying batch sizes and expiry ranges.
  • Inventory management systems integration: Warehouse Management Systems (WMS) must incorporate expiry date-based alerts and picking priorities.
  • Robust labeling and traceability: Employ barcode or RFID systems linked to batch and expiry details to prevent errors.
Also Read:  Common Mistakes in Applying FIFO and FEFO in Practice

Pharmaceutical warehouses must also maintain environmental controls per GMP standards—such as temperature and humidity monitoring—to ensure product integrity while supporting FIFO and FEFO workflows. Maintenance and cleaning SOPs should be designed to minimize disruption of stock rotation sequences.

Step 4: Implement Robust Documentation and Electronic Systems to Manage Stock Rotation

Compliance with GMP requirements demands rigorous documentation at all levels of warehouse operations supporting FIFO and FEFO.

Manual Documentation Tactics:

  • Receipt records: Documenting arrival dates and assigned storage locations.
  • Expiry date logs: Capturing shelf life data from Certificates of Analysis and batch labeling at receipt.
  • Issue/dispatch records: Recording product quantity and batch numbers leaving the warehouse, ensuring rotation sequence adherence.

Electronic Warehouse Management Systems (WMS):

  • Automated expiration tracking: Systems flag batches approaching expiry so FEFO stock can be prioritized in picking workflows.
  • Batch-level tracking: Real-time inventory updates with expiry and receipt date references.
  • Alerts and exceptions management: Notifications triggered if older stock remains unissued beyond predefined retention periods.

The use of electronic systems reduces human error risks linked to manual processing and enhances GMP traceability requirements described in ICH Q7 and Q10 guidance. Data integrity and audit trails must be maintained throughout lifecycle management.

Step 5: Train Personnel and Conduct Regular Audits to Enforce FIFO and FEFO Compliance

Even the best-designed FIFO and FEFO systems require ongoing human oversight and training to ensure sustained compliance.

Key Training Focus Areas:

  • Understanding stock rotation principles: Training warehouse operatives, QA/QC personnel, and supervisors on the rationale and operational practices of FIFO and FEFO.
  • Material handling procedures: Proper labeling, inspection during receipt and dispatch, and how to handle exceptions such as damaged or near-expiry stock.
  • Use of electronic systems: Training on WMS operation including scanning procedures and exception handling.

Audit and Inspection Activities:

  • Regular internal audits: Scheduled checks to verify adherence to FIFO and FEFO, inventory accuracy, and correct documentation.
  • Mock regulatory inspections: Preparing warehouse operations for external audits by FDA, MHRA, EMA, or PIC/S inspectors focusing on material control and GMP compliance.
  • Corrective and preventive action (CAPA): Implementing CAPA mechanisms when deviations in stock rotation are identified.
Also Read:  How to Justify and Document Reprocessing in Batch Records

These activities support a culture of continuous improvement and align warehouse operations with the standards of global regulatory authorities such as the MHRA and WHO, emphasizing quality throughout pharmaceutical supply chains.

Step 6: Manage Exceptions and Address Challenges in FIFO and FEFO Application

Pharmaceutical warehousing faces practical challenges that can disrupt ideal FIFO or FEFO stock rotation. A GMP-compliant system anticipates these issues and implements controls for exception management.

Common Challenges Include:

  • Split or mixed batch receipts: Physical separation and separate inventory records must be maintained.
  • Returned or quarantined products: Require clear segregation and dedicated processes to prevent inadvertent re-issuance based on incorrect stock rotation.
  • Damaged or compromised stock: Immediate quarantine procedures must be in place with proper disposition workflows integrated into the stock management system.
  • Expiry date changes or shelf-life extension: Require documented approval from QC and regulatory bodies before updating stock rotation parameters.

Best Practices for Exception Handling:

  • Establish SOPs for rapid identification and segregation of nonconforming products.
  • Use electronic flags in WMS to isolate problem batches from FEFO/FIFO inventory.
  • Report and document all exceptions in deviation logs, linked to CAPA actions.
  • Maintain open communication between warehouse, QA, and supply chain teams to address root causes of repeated exceptions.

By managing exceptions effectively, pharmaceutical warehouses can ensure that stock rotation practices do not compromise product quality or regulatory compliance.

Conclusion: Harmonizing FIFO and FEFO within Pharmaceutical Warehouse Operations

In regulated pharmaceutical environments across the US, UK, and EU, both FIFO and FEFO in pharmaceutical warehouses are indispensable for effective stock rotation and ensuring product quality and safety. This step-by-step tutorial has outlined how to identify which method applies to each product type, design warehouse layouts, leverage documentation and electronic systems, train personnel, and manage challenges.

Adherence to these principles supports compliance with global GMP frameworks, mitigates risks of stock expiry and wastage, and facilitates efficient supply chain operations. A comprehensive, well-documented integration of FIFO and FEFO aligns warehouse practice with regulatory expectations and ultimately protects patient safety.

FIFO & FEFO Tags:fefo, fifo, pharmagmp, stock rotation, warehouse

Post navigation

Previous Post: How to Implement FIFO and FEFO in Warehouse Management Systems
Next Post: Audit Findings on Poor Control of Material Dispensing Operations

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme